Assistant Professor Ting Fu and collaborators have identified a promising new target for treatments that could help the millions of people worldwide who suffer from inflammatory bowel disease and related colorectal cancers.
cancer
New Drug Delivery Method Harnesses Clotting to Target Anti-Cancer Drugs at Tumors
Assistant Professor Quanyin Hu has developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.
Oncology Pharmacy: Supporting Cancer Patients at Every Step
Through his involvement in several pharmacist-led initiatives at UW Health, oncology pharmacist alum Jason Bergsbaken is working to improve cancer care.
Researcher on the Rise
School of Pharmacy Assistant Professor Quanyin Hu recently earned national honors as a highly cited rising star in drug delivery By Nicole Sweeney Etter The accolades for Quanyin Hu, an assistant professor in the University …
A Continuing Tradition of Innovation
School of Pharmacy researchers in fiscal year 2021–22 received four patents for innovations in drug discovery and delivery.
New Approach Could Push Limits of Immunotherapy for Difficult-to-Treat Cancers
A recent study by Assistant Professor Quanyin Hu points toward a potential new approach for pushing the limits of immunotherapy, opening a door to more effective treatment of inoperable tumors and metastatic cancer.
New Injectable Gel Treatment Offers Promise for Tough-to-Treat Brain Tumors
School of Pharmacy Assistant Professor Quanyin Hu and collaborators publish preclinical results on a new approach to prevent glioblastoma recurrence.
Gaming for Cancer Prevention
Led by Assistant Professor Olufunmilola Abraham, a School of Pharmacy team creates a responsive, patient-focused video game for cancer education and prevention among teens.
PharmTox Student Receives Prestigious Hilldale Fellowship
With the Hilldale undergraduate research fellowship, PharmTox student Carlene Kranjac pursues better treatments for head and neck cancer.
Advanced Polymeric Nanotechnology for Delivering Combination Cancer Therapies
Professor Glen Kwon receives a new grant from the National Institutes of Health for research targeting triple-negative breast cancer.